share_log

Healthcare AI Acquisition Corp. (NASDAQ:HAIA) Sees Significant Growth in Short Interest

Financial News Live ·  Dec 13, 2022 06:31

Healthcare AI Acquisition Corp. (NASDAQ:HAIA – Get Rating) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 11,900 shares, an increase of 296.7% from the November 15th total of 3,000 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 38,700 shares, the short-interest ratio is currently 0.3 days.

Healthcare AI Acquisition Stock Up 0.4 %

HAIA traded up $0.04 on Monday, hitting $10.23. The company's stock had a trading volume of 3,802 shares, compared to its average volume of 75,527. The company's 50 day simple moving average is $10.14 and its 200-day simple moving average is $10.04. Healthcare AI Acquisition has a 12 month low of $9.82 and a 12 month high of $10.82.

Get Healthcare AI Acquisition alerts:

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of HAIA. Virtu Financial LLC purchased a new stake in Healthcare AI Acquisition in the 2nd quarter worth approximately $108,000. Basso Capital Management L.P. purchased a new stake in Healthcare AI Acquisition in the 1st quarter worth approximately $248,000. Robinson Capital Management LLC purchased a new stake in Healthcare AI Acquisition in the 2nd quarter worth approximately $263,000. PEAK6 Investments LLC purchased a new stake in Healthcare AI Acquisition in the 1st quarter worth approximately $347,000. Finally, OMERS ADMINISTRATION Corp purchased a new stake in Healthcare AI Acquisition in the 1st quarter worth approximately $396,000. 55.45% of the stock is owned by institutional investors.

About Healthcare AI Acquisition

(Get Rating)

Healthcare AI Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends on healthcare and pharmaceutical companies in the e-clinical, healthcare information technology, or outsourced pharmaceutical services industries.

See Also

  • Get a free copy of the StockNews.com research report on Healthcare AI Acquisition (HAIA)
  • Three Small-Cap Biotech Stocks to Consider Now
  • Two Blue Chip Health Companies The Institutions Are Buying
  • What To Expect From The Q4 Earnings Reporting Season
  • Here's What to Expect for the S&P 500 in 2023
  • Can Bilibili be the Chinese Version of YouTube?

Receive News & Ratings for Healthcare AI Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare AI Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment